Clinical characteristics and outcomes of paradoxical palmoplantar pustulosis during secukinumab therapy in biologic-na&#239;ve patients with plaque psoriasis: a&#160;retrospective case series.

Ilumya (tildrakizumab-asmn) - Sun Pharma, Almirall

Cosentyx (secukinumab) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42565330

Hongxia Yan; Jing Li; Li Liu; Na Zhu; Qigong Si; Qiri Mu; Rina Wu; Xigetu He; Yi Zhang; Ziqi Li

Aug 8, 2026